B
Bicycle Therapeutics plc (BCYC)
NMS – Real Time Price. Currency in USD
4.72
+0.02 (0.43%)
At close: May 12, 2026, 4:00 PM EDT
4.85
+0.13 (2.69%)
After-hours: May 12, 2026, 6:50 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
4.72
+0.02 (0.43%)
At close: May 12, 2026, 4:00 PM EDT
4.85
+0.13 (2.69%)
After-hours: May 12, 2026, 6:50 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 12.66 | 6.05 | 10 | |
| Quick ratio | 12.66 | 5.63 | 10 | |
| Debt to Equity | 0.03 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | -1492.17 | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 14M | 27M | 35M | 73M | 63M |
| Gross Profit | 11M | 21M | 28M | 66M | 57M |
| Operating Income | -138M | -216M | -252M | -283M | -276M |
| Net Income | -113M | -181M | -169M | -219M | -220M |
| EBITDA | -135M | -209M | -245M | -277M | -270M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 48.84 | 49.44 | 10 |
| Next quarter | -63.84 | 40.96 | 5.5 |
| Current year | -69.64 | 26.98 | 5.5 |
| Next year | -32.64 | -2.2 | 1.0 |
| Weighted average score | 5.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -98.14 | -201.72 | -199.99 | -238.15 | 1.0 |
| Y/Y | -91.15 | 0.43 | 1.14 | 23.8 | 4.0 |
| 3y average | 74.61 | -27.99 | 0.09 | -57.69 | 3.5 |
| 5y average | 51.83 | -36.5 | -8.47 | -137.06 | 3.3 |
| Weighted average score | 3.0 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $560.0M significantly exceed its total debt $15.9M, ensuring strong financial flexibility
Total current assets $619.1M exceed Total current liabilities $48.9M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-1,492.2x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$66.5M limits the company's ability to reinvest or pay down debt